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Prevalence of cirrhosis among older adults is expected to increase; therefore, we studied
the health status, functional disability, and need for supportive care in a large national
sample of individuals with cirrhosis. A prospective cohort of individuals with cirrhosis was
identiﬁed within the longitudinal, nationally representative Health and Retirement Study.
Cirrhosis cases were identiﬁed in linked Medicare data via ICD-9-CM (International Clas-
siﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation) codes and compared to an
age-matched cohort without cirrhosis. Two primary outcome domains were assessed: (1)
patients’ health status (perceived health status, comorbidities, health care utilization, and
functional disability as determined by activities of daily living and instrumental activities
of daily living), and (2) informal caregiving (hours of caregiving provided by a primary
informal caregiver and associated cost). Adjusted negative binomial regression was used to
assess the association between cirrhosis and functional disability. A total of 317 individuals
with cirrhosis and 951 age-matched comparators were identiﬁed. Relative to the compari-
son group, individuals with cirrhosis had worse self-reported health status, more comor-
bidities, and used signiﬁcantly more health care services (hospitalizations, nursing home
stays, physician visits; P < 0.001 for all bivariable comparisons). They also had greater
functional disability (P < 0.001 for activities of daily living and instrumental activities of
daily living), despite adjustment for covariates such as comorbidities and health care utili-
zation. Individuals with cirrhosis received more than twice the number of informal care-
giving hours per week (P < 0.001), at an annual cost of US $4700 per person. Conclusion:
Older Americans with cirrhosis have high rates of disability, health care utilization, and
need for informal caregiving. Improved care coordination and caregiver support is neces-
sary to optimize management of this frail population. (HEPATOLOGY 2012;55:184-191)
T
he prevalence of cirrhosis among older adults
is expected to increase,1 in part due to the ris-
ing incidence of nonalcoholic fatty liver dis-
ease and the aging of the hepatitis C population.2,3
Patients with cirrhosis, especially those with age-related
comorbidities, experience several potentially debilitat-
ing complications that can have a signiﬁcant impact
on activities of daily living (ADLs), such as the ability
to dress oneself, and instrumental activities of daily
living (IADLs), such as the ability to manage shop-
ping or housework. These impairments, combined
with the associated regimen of dietary restrictions,
medications, laboratory testing, and clinic visits, make
management of cirrhosis in the elderly very complex.4
Furthermore, optimal home-based care is limited
without caregivers who can help supplement the care
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that clinicians provide.5 Figure 1 presents a concep-
tual framework demonstrating how cirrhosis-related
complications, underlying psychosocial/behavioral
issues, and aging might contribute to increased care-
giver time and burden.
The importance of informal caregiving by family
members has been well described for patients with
other chronic diseases such as diabetes, congestive heart
failure, and stroke. Caregiver involvement improves
patient outcomes,6 and interventions can increase care-
giver effectiveness.7-9 Informal caregiving for these condi-
tions has also been shown to cause signiﬁcant economic
and health burdens for the caregivers.10-16 For older
adults with cirrhosis, the degree of functional impairment
and involvement of informal caregivers has not been well
described. The current study used a unique, large
national data set to assess health status and functional
disability of older individuals with cirrhosis and its com-
plications, as well as estimate the burden and cost of
informal caregiving in this population.
Patients and Methods
Human Subjects
This study was conducted using prospectively col-
lected data from the Health and Retirement Study
(HRS) linked to the Center for Medicare and Medic-
aid Services (CMS) standard analytic ﬁles. The HRS is
a biennial, longitudinal survey of a nationally represen-
tative cohort of US adults older than 50 years of age.
The HRS includes more than 22,000 Americans, with
interviews performed every 2 years, providing detailed
information on participants’ functional condition,
health status, and caregiver assistance. The HRS has
been used previously to characterize the functioning
and caregiver support for individuals with chronic dis-
eases such as congestive heart failure and diabetes.10,17
HRS respondents who met the following criteria were
included in the study population: (1) community-
dwelling (i.e., those living in skilled nursing facilities
or nursing homes were excluded), (2) completed an
interview some time between 1998-2008, and (3) age
 65 years at the time of the interview. Because HRS
surveys may not accurately identify patients with cir-
rhosis, we linked surveys to Medicare claims using
International Classiﬁcation of Diseases (ICD) codes, as
described below. The ﬁrst CMS claim date on which a
cirrhosis diagnosis was identiﬁed is referred to as the
‘‘index date.’’ The HRS interview following the index
date is referred to as the ‘‘index HRS interview,’’ and
was the source of information for the current study.
Median time from ‘‘index date’’ to ‘‘index HRS inter-
view’’ was 370 days (range, 1-1090 days); cases with-
out an interview within 3 years of the index date were
excluded from the analysis.
Cirrhosis Cases. A set of ICD-9-CM (ICD, Ninth
Revision, Clinical Modiﬁcation) codes were used to
identify cases with cirrhosis and its complications. Indi-
viduals with cirrhosis were identiﬁed from all available
Medicare claims ﬁles (carrier, inpatient, outpatient, skilled
nursing, home health, and hospice) between 1995-2007
as those individuals having at least one of the following
ICD-9-CM claims for cirrhosis (alcoholic cirrhosis,
571.2; cirrhosis not due to alcohol, 571.5) or complica-
tions of cirrhosis (hepatic encephalopathy, 572.2; ascites,
code 789.5 until 2007, then 789.59; hepatorenal syn-
drome, 572.4; esophageal varices with bleeding, 456.0,
456.2; esophageal varices without bleeding, 456.1, 456.2;
portal hypertension, 572.3; hepatocellular carcinoma,
155.0; and spontaneous bacterial peritonitis, 567.23).
Individuals identiﬁed solely by ascites code were included
only if they had two or more ascites claims on different
days in a 1-year period.
Fig. 1. Conceptual framework demonstrating how cirrhosis-related
complications, underlying psychosocial/behavioral issues and aging
contribute to increased informal caregiver burden. CAD, coronary artery
disease; CHF, congestive heart failure; COPD, chronic obstructive pul-
monary disease; CVA, cerebrovascular accident; DM, diabetes mellitus;
GI, gastrointestinal; HCC, hepatocellular carcinoma; HPS, hepatopul-
monary syndrome; HRS, hepatorenal syndrome; IDU, injection drug
use; MI, myocardial infarction.
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This algorithm was then externally validated by
reviewing patient charts for a sample of patients identi-
ﬁed by ICD-9-CM codes and receiving care at the
University of Michigan in 2008. Positive predictive
value (PPV) of the ICD-9-CM codes was determined
using a random sample of 100 outpatients and inpa-
tients with these billing codes seen at the University of
Michigan in 2008. A diagnosis of cirrhosis was deter-
mined by chart audit performed by a hepatologist, on
the basis of compatible histologic analysis; imaging
showing a cirrhotic liver with splenomegaly and a pla-
telet count of <120,000/mm3; or evidence of decom-
pensated cirrhosis with hepatic encephalopathy, hepa-
torenal syndrome, ascites, or variceal bleeding. Of
those with a veriﬁed diagnosis of cirrhosis, further
chart review was performed to determine if cirrhosis
was compensated or decompensated at the time the
ICD-9-CM code was billed. A second cohort of
patients was used to determine sensitivity of the ICD-
9-CM codes. Inpatient and outpatient billing codes
were assessed over the past 2 years for a random sam-
ple of 100 patients from another study for which
patients with cirrhosis had been enrolled prospectively.
The above validity tests showed that our algorithm of
ICD-9-CM codes had a PPV of 88% and a sensitivity
of 67%. Of the patients with a diagnosis of cirrhosis
veriﬁed by chart review, 43% had compensated and
57% had decompensated cirrhosis at the time of cod-
ing, indicating that our algorithm of ICD-9-CM codes
identiﬁed patients with both compensated and decom-
pensated cirrhosis.
Comparison Group. An age-matched cohort of
HRS respondents who did not have cirrhosis served as
a comparison group. Each cirrhosis case was matched
by age with three comparators, drawn from the pool
of HRS respondents completing surveys during the
same period and enrolled in Medicare Parts A and B
FFS (Fee-For-Service) in the month of the index date,
but without any Medicare claims indicating cirrhosis.
Data Analysis
Two primary outcome domains were assessed:
patients’ health status (perceived health status, comor-
bidities, health care utilization, and functional disabil-
ity) and informal caregiving (hours of caregiving pro-
vided by a primary informal caregiver and associated
cost). In order to determine degree of functional
decline over time, change in functional disability and
hours of informal caregiving was measured over the
time period between the HRS interview before and af-
ter the index date (ﬁrst date of cirrhosis detection by
ICD-9-CM code).
Self-reported comorbid medical illnesses included
hypertension, diabetes, cancer, chronic lung disease
(asthma, chronic obstructive lung disease), heart dis-
ease, stroke, and arthritis. Cognitive function was
measured by using a validated screening test for cogni-
tive function (35-point scale including tests of mem-
ory, serial 7 subtractions, naming, and orientation).18
Although objective testing was used for cognitive
assessment, it is important to note that these tests do
not differentiate between impairment due to hepatic
encephalopathy or competing etiologies such as Alzhei-
mer’s disease or alcohol-related dementia. On the basis
of these tests, cognitive function was categorized using
accepted cut-points into three levels of functioning:
normal, mild-to-moderate impairment, and severe
impairment. Health care utilization was measured by
the number of subjects that required hospitalization,
nursing home stay, or home health services during the
2 years prior to the index HRS survey. Number of phy-
sician visits as well as out-of-pocket medical expenses
over the duration of 2 years was also recorded.
Subjects’ ability to perform tasks of daily living was
assessed within the two commonly recognized domains
of ADLs and IADLs. ADLs include the following six
activities: eating, dressing, bathing, toileting, getting in
and out of bed, and mobility inside own residence.
ADLs were considered impaired if the subject reported
difﬁculty performing or receiving help with any of the
above six activities. IADLs include the following ﬁve
activities: cooking, grocery shopping, taking medica-
tions, managing money, and using the telephone.
IADLs were considered impaired if the subject
reported difﬁculty performing or receiving help with
any of the above ﬁve activities.
An informal caregiver was deﬁned as a family mem-
ber or unpaid relative with no organizational afﬁliation
who provided in-home care to the respondent. Data
recorded for the caregiver included sex and relationship
to the respondent. The number of hours per week of
informal caregiving was calculated using the average
number of days per week and the average number of
hours per day that the subject reported receiving infor-
mal care in the past month. The hours of caregiving
were averaged across all subjects, including those who
did not receive any caregiving.
Demographic data included sex, age, race, ethnicity,
living situation (married, unmarried living with others,
unmarried living alone), presence of children who live
within 10 miles, years of education, insurance other
than Medicare/Medicaid, and household net worth.
Cost of Informal Care. The annual cost of informal
caregiving can be estimated using opportunity cost,
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which accounts for the cost of hours sacriﬁced by the
informal caregiver in order to care for a patient by
applying a market wage rate to caregiving activ-
ities.19,20 Opportunity cost can be estimated using the
wage of an equivalent service, such as that of a home
health aide. The yearly opportunity cost of informal
caregiving for individuals with cirrhosis was estimated
by multiplying the median hourly national wage for a
home health aide (US $9.85)21  the weekly hours of
informal caregiving  52 (weeks per year). Upper and
lower bound cost estimates for informal caregiving
were created using 10th and 90th percentile hourly
wage for a home health aide, respectively (10th percen-
tile: US $7.67; 90th percentile: US $14.13). Cost esti-
mates were averaged across all subjects, including those
who did not receive any caregiving.
Statistical Analysis. Descriptive bivariate statistics
were analyzed using chi-squared and F-tests for cate-
gorical and continuous variables, respectively. Negative
binomial regression was used to estimate the independ-
ent effect of cirrhosis on number of impaired ADLs
(and IADLs). On the basis of regression results, we
calculated incident rate ratios (IRR), which is the ratio
of the incidence rate of impaired ADLs (or IADLs) in
individuals with cirrhosis relative to the rate of impair-
ment among individuals without cirrhosis. An IRR >
1 indicates that cirrhosis is associated with increased
impairment in functional status compared to their age-
matched controls. The model was adjusted for poten-
tial confounders known to be associated with cirrhosis
and independently associated with poor functional sta-
tus (age, sex, race, ethnicity, schooling, net worth, liv-
ing arrangement, comorbidities, and insurance other
than Medicare/Medicaid). Comorbidities were entered
into the model as seven separate binary indicators, one
for each comorbid condition. Cognitive impairment
was intentionally excluded from this model, because
neurocognitive dysfunction may directly result from
cirrhosis and thus be a pathway to disability rather
than a confounder. To determine whether health care
utilization confounded the association between cirrho-
sis and disability, a sensitivity analysis was performed
by creating an interaction variable between presence of
cirrhosis and number of physician visits (over the du-
ration of 2 years) and including it as a covariate in the
regression model. All analyses were carried out using
SAS version 9.1.3 (SAS Institute, Cary, NC) and were
adjusted for the matched case–comparator design. The
study protocol conformed to the ethical guidelines of
the 1975 Declaration of Helsinki as reﬂected in a pri-
ori approval by the appropriate institutional review
committee.
Results
Study Population Characteristics
We identiﬁed 317 cases with cirrhosis and 951 com-
parators in the linked HRS–Medicare data. Relative to
the comparison group, individuals with cirrhosis were
more likely to be Hispanic (P < 0.001), have less edu-
cation (P ¼ 0.001), and have lower net worth (P ¼
0.040) (Table 1). The two groups were similar with
respect to the proportion of individuals with insurance
other than Medicare/Medicaid (P ¼ 0.091).
Health Status and Functional Disability
Individuals with cirrhosis had a greater number of
medical comorbidities (P < 0.001) than those in the
comparison group, worse perceived health status (P <
0.001), and more severe cognitive impairment (P ¼
0.001) (Table 2). They also required more than double
the health care services (hospitalizations, nursing home
stays, and physician visits; P < 0.001 for all) and had
signiﬁcantly higher out-of-pocket medical expenses
(P ¼ 0.001) compared to those without cirrhosis, yet
only 25% reported receiving home health services.
One-quarter of individuals with cirrhosis reported their
health status as ‘‘poor’’, compared to only 11% of those
without cirrhosis (P < 0.001 for the trend; Table 2).
Individuals with cirrhosis had greater impairment of
ADLs compared to the comparison group (P <
0.001), with 38% indicating at least one impaired
ADL (Table 3). Overall, 14% of individuals with cir-
rhosis could perform only 0-2 of their ADLs (i.e., 4-6
Table 1. Demographic Characteristics of Patients with
Cirrhosis and Comparison Group*
Variable
Cirrhosis Cases
(n ¼ 317)
Comparison Group
(n ¼ 951) P Value
Age (years) 74.7 6 0.4 74.7 6 0.2 0.68
Sex (Male) 143 (45.1) 393 (41.3) 0.24
Race/ethnicity
White 227 (71.6) 797 (83.8) <0.001
Black 45 (14.2) 98 (10.3)
Hispanic 40 (12.6) 49 (5.2)
Other 5 (1.6) 7 (0.7)
Education (years) 11.0 6 0.2 11.7 6 0.1 0.001
Living arrangement
Married, living
with spouse
172 (54.3) 553 (58.2) 0.35
Unmarried, living
with others
50 (15.8) 117 (12.3)
Unmarried, living alone 95 (30.0) 281 (29.6)
Children within 10 miles 203 (65.1) 555 (59.7) 0.14
Household net
worth (US$)†
102,439
(27,600-292,500)
181,513
(43,926-493,178)
0.04
*Data presented as (mean 6 standard error) for continuous variables, n (%)
for categorical variables.
†Median (interquartile range).
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impaired ADLs). IADLs were similarly impaired, with
10% of individuals with cirrhosis able to perform only
0-1 IADLs (i.e., 4-5 impaired IADLs). The most com-
mon ADL and IADL impairments among those with
cirrhosis were ‘‘dressing’’ and ‘‘grocery shopping’’,
respectively. After adjusting for covariates associated
with functional disability, having cirrhosis was inde-
pendently associated with impaired ADLs (adjusted
IRR ¼ 1.50, P ¼ 0.004) and impaired IADLs
(adjusted IRR ¼ 1.72, P < 0.001) (Table 4). In other
words, after adjustment, those with cirrhosis experi-
enced 1.50 times more ADL impairments and 1.72
times more IADL impairments compared to those
without cirrhosis. Sensitivity analysis using an interac-
tion variable between cirrhosis and number of physi-
cian visits revealed no signiﬁcant interaction between
cirrhosis and health care utilization (ADL model: P ¼
0.33; IADL model: P ¼ 0.80). In fact, greater use of
health care services correlated more strongly with dis-
ability among the comparison group than among the
cirrhosis group (data not shown). Thus, health care
utilization does not confound the independent associa-
tion between cirrhosis and disability.
Receipt of Informal Care
One-third of individuals with cirrhosis identiﬁed a
caregiver (formal or informal), with less than 10% of
Table 2. Self-Reported Health Status and Medical
Conditions of Patients with Cirrhosis and
Comparison Group*
Variable
Cirrhosis Cases
(n ¼ 317)
Comparison Group
(n ¼ 951) P Value
Perceived health status
Excellent 16 (5.1) 96 (10.1) <0.001
Very good/good/fair 223 (70.6) 747 (78.6)
Poor 77 (24.3) 107 (11.3)
Perceived pain
None 187 (59.0) 669 (70.7) <0.001
Mild/moderate 96 (30.3) 212 (22.4)
Severe 34 (10.7) 65 (6.9)
Medical comorbidities§
Hypertension 185 (58.4) 534 (56.3) 0.55
Diabetes 97 (30.6) 169 (17.8) <0.001
Cancer 74 (23.4) 153 (16.1) 0.005
Lung disease 56 (17.7) 96 (10.1) <0.001
Heart disease 133 (42.1) 290 (30.6) <0.001
Stroke 51 (16.1) 105 (11.1) 0.02
Arthritis 212 (66.9) 589 (62.0) 0.10
Number of medical comorbidities 2.6 6 0.08 2.0 6 0.04 <0.001
Cognitive impairment
None 175 (55.4) 635 (66.8) 0.001
Mild-moderate 92 (29.1) 204 (21.5)
Severe 49 (15.5) 112 (11.8)
Hospital stay† 212 (66.9) 311 (32.7) <0.001
Nursing home stay† 55 (17.4) 53 (5.6) <0.001
Home health services† 74 (24.8) 98 (10.6) <0.001
Number of physician visits† 20.5 6 2.4 10.8 6 0.5 <0.001
Out-of-pocket medical
expenses (US$)†,‡
2150
(526-5379)
1459
(433-3709)
0.001
*Data presented as (mean 6 standard error) for continuous variables, n (%)
for categorical variables.
†Over the past 2 years, self-reported.
‡Median (interquartile range).
§Patient could indicate more than one comorbidity.
Table 3. Functional Status of Patients with Cirrhosis and
Comparison Group*
Variable
Cirrhosis Cases
(n ¼ 317)
Comparison Group
(n ¼ 951) P Value
Number of impaired ADLs
0 195 (61.5) 722 (75.9) <0.001
1-3 79 (24.9) 166 (17.5)
4-6 43 (13.6) 63 (6.6)
Type of ADL impairment§
Walking across room 63 (19.9) 110 (11.6) 0.001
Dressing 76 (24.0) 139 (14.6) <0.001
Bathing 71 (22.4) 114 (12.0) <0.001
Transferring 46 (14.6) 86 (9.1) 0.005
Toileting 52 (16.5) 91 (9.6) <0.001
Eating 36 (11.4) 58 (6.1) 0.002
Loss of ADLs over time†,‡
< 0 25 (8.6) 66 (7.7) 0.001
0 180 (62.1) 641 (74.7)
1 32 (11.0) 76 (8.9)
>2 53 (18.3) 75 (8.7)
Number of impaired IADLs
0 204 (64.4) 753 (79.3) <0.001
1-3 80 (25.2) 146 (15.5)
4-5 33 (10.4) 50 (5.3)
Type of IADL impairment§
Grocery shopping 91 (30.3) 135 (14.8) <0.001
Managing money 65 (21.5) 96 (10.5) <0.001
Cooking 63 (21.7) 102 (11.6) <0.001
Taking medication 41 (13.1) 47 (5.1) <0.001
Using the telephone 38 (12.1) 77 (8.2) 0.026
Loss of IADLs over time†,‡
< 0 13 (4.5) 42 (5.0) <0.001
0 187 (64.9) 673 (79.3)
1 35 (12.2) 68 (8.0)
>2 53 (18.4) 66 (7.8)
*Data presented as (mean 6 standard error) for continuous variables, n (%)
for categorical variables.
†Category of < 0 indicates gain in ADLs (functional improvement); >0 indi-
cates loss of ADLs (functional decline).
‡Median ¼ 2.1 years (time between pre-index date survey and post-index
date survey). Cirrhosis cases: n ¼ 290; comparison group: n ¼ 858.
§Patients could have more than one ADL or IADL impairment.
Table 4. Incident Rate Ratio (IRR) of the Association
Between Cirrhosis and Functional Disability
IRR* Cirrhosis No Cirrhosis P Value
Impaired ADLs
Unadjusted 1.73 (1.38-2.15) Ref. <0.001
Adjusted† 1.50 (1.14-1.97) Ref. 0.004
Impaired IADLs
Unadjusted 1.95 (1.55-2.46) Ref. <0.001
Adjusted† 1.72 (1.30-2.29) Ref. <0.001
*IRR >1 indicates that cirrhosis is associated with higher incidence rate of
functional disability (impaired ADL or IADL) compared to no cirrhosis.
†Adjusted for age, sex, race, ethnicity, schooling, net worth, living arrange-
ment, medical comorbidities, and insurance other than Medicare/Medicaid.
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patients receiving formal (paid) care. Individuals with
cirrhosis received more than twice the informal care-
giving hours relative to the comparison group (P <
0.001), with informal care most often provided by the
subjects’ children (Table 5).
Change in Functional Status and Caregiving
Over Time
Change in functional status and caregiving was
determined using data from the HRS interview before
and after the index date (i.e., ﬁrst date of cirrhosis
detection by ICD-9-CM code). Median time from the
pre–index date interview until the post–index date
interview was 775 days (2.1 years), with a range of
474-1853 days. Cases without an interview within 3
years prior to the index date were excluded from this
pre- and post-index analysis. All cirrhosis cases and
comparators completed an HRS survey after the index
date; however, some did not have an HRS survey per-
formed prior to the index date. Therefore, 9% of
patients with cirrhosis and 10% of controls were
excluded from these analyses, leaving a sample of 290
cases with cirrhosis and 858 comparators. Nearly 30%
of patients with cirrhosis demonstrated functional
decline over the pre- to post-index time period (me-
dian 2.1 years), as deﬁned by loss of at least one or
more ADLs. Moreover, 18% of individuals with cir-
rhosis had severe functional decline (loss of two or
more ADLs), doubling that of the age-matched com-
parison group (Table 3). A similar rate of functional
decline was seen for IADLs (Table 3). Over the pre-
and post-index time period, individuals with cirrhosis
received 6.8 additional hours of informal caregiving
per week, more than twice as much as the increase in
the age-matched comparison group (Table 5).
Annual Cost of Informal Caregiving
Using the 2009 median national wage for a home
health aide (US $9.85 per hour20), the annual cost of
informal caregiving for elderly individuals with cirrho-
sis was US $4700 per person, compared to US $2100
for age-matched elderly individuals without cirrhosis.
Using the 10th and 90th percentile hourly national
wage for a home health aide, annual cost of informal
caregiving ranged from US $3700 to US $6700 for
patients with cirrhosis and from US $1600 to US
$2900 for patients without cirrhosis.
Discussion
In this nationally representative sample of older
Americans, we found that individuals with cirrhosis had
signiﬁcantly worse health status and greater functional
disability compared to those without cirrhosis, requiring
nearly twice the amount of informal caregiving at an
annual societal cost of approximately US $4700 per
individual. Nearly 20% of subjects with cirrhosis experi-
enced severe functional decline (loss of two or more
ADLs) over a median of approximately 2 years, more
than doubling that of age-matched individuals without
cirrhosis. As the incidence of nonalcoholic fatty liver
disease increases and the population infected with hepa-
titis C virus ages, cirrhosis among the elderly will
become increasingly prevalent and is expected to impose
a signiﬁcant burden to patients and their caregivers.
In addition to the potential burden to caregivers,
individuals with cirrhosis also strain the health care
system. Annually, cirrhosis results in 50,000 hospital-
izations22; of those who survive hospitalization,
approximately 20% are readmitted within 30 days.23
Our ﬁndings show that more than two-thirds of indi-
viduals with cirrhosis report being admitted to the
hospital within the prior 2 years, an incidence twice
that of age-matched individuals without cirrhosis.
Moreover, fewer than one-quarter of individuals with
cirrhosis received home health care services after hospi-
tal discharge, indicating a potentially lost opportunity
for improved care transitions. In other diseases,
improving patient and caregiver knowledge about
Table 5. Patterns of Receiving Care for Patients with
Cirrhosis and Comparison Group*
Variable
Cirrhosis Cases
(n ¼ 317)
Comparison Group
(n ¼ 951) P Value
Receiving care
Informal 99 (31.2) 157 (16.5) <0.001
Formal 29 (9.2) 47 (4.9) 0.006
Any (formal or informal) 105 (33.1) 170 (17.9) <0.001
Sex of informal caregiver
Male 38 (38.4) 66 (42.0) 0.56
Female 73 (73.7) 114 (72.6) 0.84
Relationship of informal
caregiver to patient†
Child/children 57 (57.6) 93 (59.2) 0.79
Spouse 41 (41.4) 55 (35.0) 0.30
Grandchild 6 (6.1) 14 (8.9) 0.41
Other caregiver 20 (20.2) 31 (19.8) 0.93
Informal care received
(hours per week)
9.14 6 1.42 4.00 6 0.59 <0.001
Increase in informal care
received over time‡
(hours per week)
6.78 6 1.32 2.75 6 0.56 <0.001
*Data presented as (mean 6 standard error) for continuous variables, n (%)
for categorical variables.
†Patient was able to indicate more than one informal caregiver; Among those
with at least one informal caregiver
‡Median ¼ 2.1 years (time between pre-index date survey and post-index
date survey). Cirrhosis cases: n ¼ 290; comparison group: n ¼ 858.
HEPATOLOGY, Vol. 55, No. 1, 2012 RAKOSKI ET AL. 189
chronic disease management and integrating caregivers
in the health care process have been shown to signiﬁ-
cantly decrease hospital admission rates.24,25 Our ﬁnd-
ings suggest that applying these concepts and services
among patients with cirrhosis has the potential to
result in signiﬁcant cost savings.
It is important to emphasize this study compared
subjects with cirrhosis to age-matched individuals, not
healthy controls. As expected with advancing age, indi-
viduals in the comparison group had several comorbid-
ities (e.g., arthritis in 62%, cardiac disease in 31%, dia-
betes in 18%, and cancer in 16%; Table 2), all of which
can be independently associated with signiﬁcant func-
tional decline and cost. Thus, the current study high-
lights the incremental disability, cost, and caregiver bur-
den of cirrhosis, even relative to other serious chronic
illnesses. Future research is needed to examine the role
that speciﬁc cirrhosis-related complications (such as
muscle wasting, hepatic encephalopathy, and ascites)
contribute to the overall disability found in this study.
To our knowledge, this is the ﬁrst study to use a
population-based sample to quantify functional disabil-
ity and the impact on formal and informal care of
individuals with cirrhosis. For comparison, a similar
study of the HRS data set showed that individuals
with congestive heart failure require an average of 6.7
hours of informal care per week, which is 2.5 fewer
hours per week than the care requirements of those
with cirrhosis.10 Data such as these have been used to
demonstrate the need and potential efﬁcacy of innova-
tive programs that provide caregiver training and edu-
cation,26,27 improve communication between provider
and patients or caregivers (e.g., telemedicine),8,28 and
create infrastructure for comprehensive chronic disease
management29 and postdischarge transitional care.30,31
As evidenced by our ﬁndings, patients with cirrhosis
require similar support for basic activities such as bath-
ing and taking medications, thereby necessitating the
intervention of informal caregivers to help prevent
potential poor outcomes (e.g., falls, missed appoint-
ments, medication noncompliance). Moreover, the sig-
niﬁcantly lower education level found in our study
emphasizes that individuals with cirrhosis may have
poor knowledge and coping strategies for managing
their chronic disease, further contributing to functional
disability. At present, there are few structured services
that promote patient education and self-care or care-
giver support for the population with cirrhosis.
Our study has some limitations that warrant com-
ment. Although there are several studies that have
deﬁned cirrhosis using ICD-9 codes,32-35 prior meth-
ods have not been validated. In order to maximize
speciﬁcity, we selected a narrow spectrum of ICD-9-
CM codes, and therefore may have excluded patients
with well-compensated cirrhosis that are either unaware
of diagnosis, asymptomatic with no prior history of
decompensation, or who have limited interaction with
the health care system. Similarly, it is possible that a
small percentage of the comparison group may have
undiagnosed cirrhosis. In addition, our study popula-
tion may have excluded patients who lack comorbidities
that would prompt medical care for reasons other than
cirrhosis. However, we would expect a similar phenom-
enon in the comparison group, and therefore, both
groups may equally consist of ‘‘sicker’’ patients. Also,
the current study lacked histological, laboratory, or
imaging data to conﬁrm cirrhosis diagnosis. Although
data such as medical comorbidities and health care utili-
zation (hospitalization, nursing home, physician visits)
were self-reported, several studies have demonstrated
the accuracy of self-reported diagnoses.36-39 Finally,
because cases were identiﬁed via linkage with the CMS
database, our ﬁndings are limited to individuals with
cirrhosis who are aged 65 or older.
Other limitations of our study involve our method
for estimating cost, which likely resulted in an under-
estimate of the cost of informal caregiving. Estimates
were based on caregiving from family members only,
and did not include costs associated with caregiving
from nonfamily members (e.g., friends, neighbors).
Moreover, cost estimates were based only on assistance
with ADLs and IADLs and did not include other
time-consuming caregiving activities such as transpor-
tation to a hospital for clinic visits, laboratory tests,
paracenteses, or variceal banding. Similarly, our cost
estimates do not include other signiﬁcant caregiving
costs such as out-of-pocket expenses related to medica-
tions, medical supplies, or lost wages (patient or care-
giver) related to cirrhosis. A recent study by Bajaj
et al. highlighted these other cirrhosis-related expenses
and the detrimental effect they can have on patients’
ability to adhere to medical recommendations.4
This population-based study conﬁrms the signiﬁcant
burden and cost that cirrhosis and its complications
places upon the patient and caregiver, as well as the
health care system. Clinicians should be aware of the
increased need for informal caregiving among patients
with cirrhosis, especially older individuals with other
age-related comorbidities. In addition, health care
economists and policy makers should consider the sig-
niﬁcant functional limitations of this population as
well as the substantial hours of informal caregiving
required to help avert preventable poor outcomes
related to the patients’ inability to independently
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manage their disease. Greater focus on a comprehen-
sive delivery of care for patients with cirrhosis, includ-
ing involvement of caregivers and improved care coor-
dination, is necessary to optimize management of this
frail population.
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